Cell Separation Market Size, Share & Trends Report

Cell Separation Market Size, Share & Trends Analysis Report By Technique (Surface Marker, Filtration), By Cell Type (Human, Animal), By Application (Cancer Research, Stem Cell Research), By Product, By End-use, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-707-0
  • Number of Report Pages: 135
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2022
  • Forecast Period: 2024 - 2030 
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the cell separation market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for cell separation market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of cell separation market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Cell Separation Market Categorization:

The cell separation market was categorized into six segments, namely product (Consumables, Instruments), cell type (Human Cells, Animal Cells), technique (Centrifugation, Surface Marker, Filtration), application (Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration, In Vitro Diagnostics, Therapeutics), end-use (Research laboratories and institutes, Biotechnology and biopharmaceutical companies, Hospitals and diagnostic laboratories, Cell banks), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).

Segment Market Methodology:

The cell separation market was segmented into product, cell type, technique, application, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The cell separation market was analyzed at a regional level. The global was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico, Argentina; South Africa; Saudi Arabia, UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Cell separation market companies & financials:

The cell separation market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Thermo Fisher Scientific, Inc.: Thermo Fisher Scientific, Inc. is a developer and supplier of analytical equipment, instruments, consumables, reagents, software, & services for various applications, including diagnostics, research, manufacturing, & drug discovery. The company operates across four business segments: Analytical Instruments, Life Sciences Solutions, Specialty Diagnostics, and Laboratory Products & Services. Through the Life Sciences Solutions segment, it provides reagents, consumables, and instruments used in drug discovery as well as biological & medical research. Through the Analytical Instruments segment, it provides consumables, instruments, software, and services used for a range of applications in the laboratory, on the production line & in the field. Its Specialty Diagnostics segment offers diagnostic reagents, test kits, instruments, culture media, and associated products for customers in healthcare, clinical, pharmaceutical, industrial, & food safety laboratories. Its Laboratory Products and Services segment offers a wide array of laboratory equipment.

  • BD: BD is a medical technology company that serves clinical laboratories, life sciences researchers, and healthcare institutions & industries. The company manufactures and markets a wide range of medical devices, diagnostic products, medical supplies, & laboratory equipment. It operates in three business segments: BD Diagnostics, BD Medical, and BD Biosciences. The BD provides products for safe collection & transportation of diagnostic specimens and reagent systems & instruments that accurately detect a broad range of healthcare-associated infections, infectious diseases, & cancer. The diagnostic systems segment offers fully automated molecular systems that provide rapid results, require less hands-on time, and are easy to use.

  • Danaher: Danaher designs, manufactures, & markets industrial, medical, and commercial products & services worldwide. The company primarily offers products and services through three segments: Diagnostics, Life Sciences, and Environmental & Applied Solutions. The life sciences segment offers technologies for purification, filtration, & separation solutions for various fields, such as medical research, biopharmaceuticals, and food & beverages. It also provides reagents, analytical instruments, consumables, and services for laboratories, hospitals, & other care centers.

  • Terumo Corporation: Terumo Corporation is a Japanese medical company involved in the manufacturing & marketing of medical products and equipment, including pharmaceuticals, disposable medical devices, cardiovascular systems, blood bags, vascular grafts, peritoneal dialysis, medical electronic, digital thermometers, etc. The company operates its business through three segments: cardiac and vascular company, general hospital company, and Blood and Cell Technologies (BCT).

  • STEMCELL Technologies: STEMCELL Technologies Inc. is involved in the development and supply of systems, products, and accessories for life science research. Products offered by the company include cell culture media and cell separation products. These products have applications in various research fields including neuroscience, hematology, stem cells, immunology, epithelial cell biology, and mesenchymal cells. It also offers instruments, antibodies, cytokines, contract assay, and proficiency testing services. The company operates in over 80 countries across the world, serving as research tools for embryonic cells, neural stem cells, hematopoietic stem cells, induced pluripotent stem cells, and other types of cells.

  • Bio-Rad Laboratories: Bio-Rad Laboratories, Inc. provides tools & services for clinical diagnostics, food sciences, and life sciences research markets. The company operates through two segments: clinical diagnostics and life sciences. Clinical diagnostics involves the design, manufacture, support, and sales of informatics systems, test systems, quality control, & test kits. These products serve clinical laboratories in the global market. Its Life sciences segment involves the creation and discovery of tools required in biological processes. The company manufactures reagents, apparatus, and laboratory instruments used in the production of biopharmaceuticals, research techniques, & food testing regimes. Bio-Rad products are used in hospitals, research institutions, laboratories, biotechnology companies, and pharmaceutical firms.

  • Merck KGaA: Merck KGaA provides a wide range of pharmaceutical and chemical products catering to various industries. This company operates through three business sectors: healthcare, life science, and performance materials. It offers life sciences products and services for drug discovery & development, along with research and laboratory applications. In the U.S. and Canada, the company operates its life sciences business as MilliporeSigma, its biopharmaceutical business as EMD Serono, and its materials as EMD Performance Materials. MilliporeSigma deals in the development of critical raw materials, contract manufacturing services, and pharmaceutical safety testing services.

  • Miltenyi Biotec: The company is a leading supplier of products & services that support cell & gene therapy and advanced biomedical products. More than 4,700 workers across 23 countries combine outstanding research with novel products to develop innovative therapies that put cancer and other diseases at ease. Its expertise ranges from clinical research fields like hematology, graft engineering, & apheresis to basic science fields like stem cell biology, neurological science, and cancer.

  • GenScript: GenScript Biotech offers products and services for life sciences research. It is known for gene synthesis capability, a frequently employed service by academics, biotech firms, and pharmaceutical firms globally. Life sciences research products & services and biologics development services under the ProBio brand, & industrial enzymes under the Bestzyme brand are some of its product & service offerings.

  • Corning Incorporated: Corning operates through various segments such as optical communications, specialty materials, environmental technologies, hemlock, and emerging growth business. The life sciences segment has been a major innovator, manufacturer, and global supplier of laboratory products. The segment offers creative solutions that boost productivity and enable breakthrough research for conventional small molecules, chemicals, drugs, biologics, vaccines, and emerging cell & gene therapies. It is accomplished by utilizing special expertise in the areas of materials science, polymer surface science, cell culture, and cell biology.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Cell Separation Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2022, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Cell Separation Market Report Assumptions:

  • The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation



This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon